nivolumab,ipilimumab
bms
['lcsm,(-blcsm)', 'nivo', 'nsclc', 'nivolumab', 'sclc', 'ipilimumab']
only an academic trial would compare short vs extended immunotherapy treatment. 6-months nivolumab + ipilimumab versus continuation in patients with nsclc (ifct-1701 trial) unfortunately halted, but important signal: not detrimental, and safer! #lcsm #esmo22 
Medical Oncology ?? HGU Gregorio Marañón?@myESMO Faculty ?? Lung Cancer - Mesothelioma - Thymoma?Power to the patients #endlungcancer #lcsm